Principal Financial Group Inc. Buys 33,869 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Principal Financial Group Inc. raised its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 33.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 136,302 shares of the biotechnology company’s stock after acquiring an additional 33,869 shares during the period. Principal Financial Group Inc.’s holdings in Axon Enterprise were worth $54,466,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Quent Capital LLC grew its holdings in Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after acquiring an additional 75 shares during the last quarter. Blue Trust Inc. increased its holdings in shares of Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after acquiring an additional 79 shares in the last quarter. Friedenthal Financial bought a new stake in Axon Enterprise during the 3rd quarter worth approximately $51,000. Reston Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the third quarter worth $60,000. Finally, Asset Dedication LLC bought a new stake in shares of Axon Enterprise in the second quarter valued at about $47,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total transaction of $437,980.00. Following the transaction, the director now directly owns 26,259 shares of the company’s stock, valued at approximately $11,500,916.82. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total value of $437,980.00. Following the transaction, the director now owns 26,259 shares of the company’s stock, valued at approximately $11,500,916.82. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Patrick W. Smith sold 80,300 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total value of $29,853,934.00. Following the sale, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at $1,121,052,771.48. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 369,172 shares of company stock worth $136,270,842. Corporate insiders own 6.10% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently commented on the company. Craig Hallum raised their price target on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. Needham & Company LLC boosted their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday. Barclays raised their price objective on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. Northland Securities boosted their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research report on Thursday, August 8th. Finally, The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and an average price target of $412.42.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $603.18 on Monday. The company has a market cap of $45.58 billion, a P/E ratio of 155.86, a PEG ratio of 15.15 and a beta of 0.94. The business has a 50-day moving average price of $414.16 and a two-hundred day moving average price of $347.59. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a 1-year low of $212.88 and a 1-year high of $611.88.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.